#retatrutide Retatrutide Side Effects: What Patients Should Know Retatrutide, an investigational triple hormone

In January 2024, the FDA announced it was investigating semaglutide for several potential safety signals, including blood clots, alongside hair loss, aspiration risk, and suicidal ideation

Nathanson D, Erdogdu O, Pernow J, Zhang Q, Nystrom T

As we expand our understanding of the clinical utility of semaglutide, it is crucial to address the limitations noted in the current research landscape

Lynn AM, Harmsen WS, Aniwan S, Tremaine WJ, Loftus EV

In a bowl, mix together the ricotta, spinach and half the sea salt until well combined

and Novo Nordisk A/S to agree to price concessions on their blockbuster weight-loss medications, in exchange for a promised expansion of Medicare coverage for the therapies